Xconomy -- There’s a new round of interesting court filings in Boston-based Dana-Farber Cancer Institute’s lawsuit against a Bay Area biotech startup co-founded by Dana-Farber scientists. It’s the latest chapter in a case primarily concerning who has rights to a potential game-changing drug for lung cancer discovered at Dana-Farber.
